Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 159 citing articles:

Ovarian Tumorigenesis
Ie‐Ming Shih, Robert J. Kurman
American Journal Of Pathology (2004) Vol. 164, Iss. 5, pp. 1511-1518
Open Access | Times Cited: 1190
Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association
Eduardo Antônio Donadi, Erick C. Castelli, Antonio Arnaiz‐Villena, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 369-395
Open Access | Times Cited: 352
HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
Deregulation of HLA-I in cancer and its central importance for immunotherapy
Ahmet Hazini, Kerry Fisher, Leonard W. Seymour
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002899-e002899
Open Access | Times Cited: 137
HLA-G Molecules: from Maternal–Fetal Tolerance to Tissue Acceptance
Edgardo D. Carosella, Philippe Moreau, Joël Le Maoult, et al.
Advances in immunology (2003), pp. 199-252
Closed Access | Times Cited: 371
Expression of HLA-G in human cornea, an immune-privileged tissue
Magali Le Discorde, Philippe Moreau, Patrick Sabatier, et al.
Human Immunology (2003) Vol. 64, Iss. 11, pp. 1039-1044
Open Access | Times Cited: 255
HLA-G Proteins in Cancer: Do They Provide Tumor Cells with an Escape Mechanism?
Nathalie Rouas‐Freiss, Philippe Moreau, Soldano Ferrone, et al.
Cancer Research (2005) Vol. 65, Iss. 22, pp. 10139-10144
Open Access | Times Cited: 241
HLA-G is a potential tumor marker in malignant ascites.
Gad Singer, Vera Rebmann, Yu‐Chi Chen, et al.
PubMed (2003) Vol. 9, Iss. 12, pp. 4460-4
Closed Access | Times Cited: 191
The immunosuppressive molecule HLA-G and its clinical implications
Álvaro González, Vera Rebmann, Joël LeMaoult, et al.
Critical Reviews in Clinical Laboratory Sciences (2012) Vol. 49, Iss. 3, pp. 63-84
Closed Access | Times Cited: 190
Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer
Shang-rong Ye, Hong Yang, Ke Li, et al.
Modern Pathology (2007) Vol. 20, Iss. 3, pp. 375-383
Open Access | Times Cited: 159
Transcriptional and Posttranscriptional Regulations of theHLA-GGene
Erick C. Castelli, Luciana C. Veiga‐Castelli, Layale Yaghi, et al.
Journal of Immunology Research (2014) Vol. 2014, pp. 1-15
Open Access | Times Cited: 150
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 417-431
Open Access | Times Cited: 133
Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 121
Molecular Pathways: Human Leukocyte Antigen G (HLA-G)
Giuseppe Curigliano, Carmen Criscitiello, Lucia Gelao, et al.
Clinical Cancer Research (2013) Vol. 19, Iss. 20, pp. 5564-5571
Closed Access | Times Cited: 120
HLA-G Molecules in Autoimmune Diseases and Infections
Roberta Rizzo, Daria Bortolotti, Silvia Bolzani, et al.
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 110
Similarities Between Embryo Development and Cancer Process Suggest New Strategies for Research and Therapy of Tumors: A New Point of View
Giovanni Manzo
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 97
Biology and functions of human leukocyte antigen‐G in health and sickness*
Joël LeMaoult, Magali Le Discorde, Nathalie Rouas‐Freiss, et al.
Tissue Antigens (2003) Vol. 62, Iss. 4, pp. 273-284
Closed Access | Times Cited: 178
HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia
Holger Nückel, Vera Rebmann, Jan Dürig, et al.
Blood (2004) Vol. 105, Iss. 4, pp. 1694-1698
Open Access | Times Cited: 162
HLA-G gene repression is reversed by demethylation
Philippe Moreau, Gaël Mouillot, Philippe Rousseau, et al.
Proceedings of the National Academy of Sciences (2003) Vol. 100, Iss. 3, pp. 1191-1196
Open Access | Times Cited: 153
Secretion of sHLA-G molecules in malignancies
Vera Rebmann, Jens P. Regel, D. Stolke, et al.
Seminars in Cancer Biology (2003) Vol. 13, Iss. 5, pp. 371-377
Closed Access | Times Cited: 137
Exosomes bearing HLA-G are released by melanoma cells
Béatrice Riteau, Florence Faure, Catherine Menier, et al.
Human Immunology (2003) Vol. 64, Iss. 11, pp. 1064-1072
Closed Access | Times Cited: 128
Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA‐G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients
Solène Le Rond, Joël Le Maoult, Caroline Créput, et al.
European Journal of Immunology (2004) Vol. 34, Iss. 3, pp. 649-660
Open Access | Times Cited: 121
Hypoxia Modulates HLA-G Gene Expression in Tumor Cells
Gaël Mouillot, Céline Marcou, Inès Zidi, et al.
Human Immunology (2006) Vol. 68, Iss. 4, pp. 277-285
Closed Access | Times Cited: 113
Expression of Human Leukocyte Antigen G (HLA-G) Correlates with Poor Prognosis in Gastric Carcinoma
Shang-mian Yie, Hong Yang, Shang-rong Ye, et al.
Annals of Surgical Oncology (2007) Vol. 14, Iss. 10, pp. 2721-2729
Closed Access | Times Cited: 106
HLA-G Neo-Expression on Tumors
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top